Cardiovascular Disease
📧 Sign up to get email alerts when something new happens for Cardiovascular Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study [Phase 2]
Phase 2 dose-finding trial of olpasiran evaluating lipoprotein(a) reduction and cardiovascular event outcomes, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Targeting Physical Activity to Improve Cardiovascular Health in Type 2 Diabetes [NA]
A completed clinical trial evaluating the impact of targeted physical activity to improve cardiovascular health in people with type 2 diabet…
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: Vascular Risk After Kidney Transplantation
Clinical trial update reporting vascular risk after kidney transplantation with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Contribution of Dolutegravir to Obesity and Cardiovascular Disease [Phase 4]
A Phase 4 clinical trial evaluating the contribution of dolutegravir to obesity and cardiovascular disease in HIV-1 infection has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: A Smartphone-based Application Post-myocardial Infarction to Manage Cardiovascular Disease Risk [NA]
A completed clinical trial evaluated a smartphone-based application to manage cardiovascular disease risk after myocardial infarction in pat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Effects of Eplerenone on Cardiovascular Disease in HIV (MIRACLE HIV Study) [NA]
A completed clinical trial evaluating the effects of eplerenone on cardiovascular disease in people with HIV.
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: PREVENT Tool Study: Late Effects Clinic [NA]
A completed clinical trial update for the PREVENT Tool Study in a late effects clinic, focusing on cardiovascular disease and childhood obes…
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk [Phase 2]
Phase 2 trial evaluating IL-1β inhibition to reduce inflammation and cardiovascular risk in people with HIV and cardiovascular disease; resu…
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM [Phase 3]
Phase 3 trial evaluating REX-001 for ischemic ulcers in patients with Critical Limb Ischemia (CLI) and diabetes was terminated.
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: Congenital Heart Disease Physical Activity Lifestyle Study [NA]
A completed clinical trial on physical activity lifestyle in congenital heart disease, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer [Phase 2]
Phase 2 trial evaluating prevention of cardiovascular diseases in women with breast cancer undergoing complex treatment; completed.
-
CLINICAL_TRIALS trial_result · 2023-01-11Clinical Trial Update: Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries [Phase 3]
Amgen's Fourier open-label extension study in adults with clinically evident cardiovascular disease and dyslipidemia was terminated, with re…
-
CLINICAL_TRIALS trial_result · 2023-01-11Clinical Trial Update: Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Participants With Hypertriglyceridemia and Established Cardiovascular Disease (CVD) [Phase 2]
Phase 2 trial of ISIS 678354 (AKCEA-APOCIII-LRx) in participants with hypertriglyceridemia and established cardiovascular disease completed …
-
CLINICAL_TRIALS trial_result · 2022-12-13Clinical Trial Update: SPREAD-NET: PRactices Enabling Adapting and Disseminating in the Safety NET [NA]
A completed clinical trial update from the SPREAD-NET study. No phase information available.
-
CLINICAL_TRIALS trial_result · 2022-11-22Clinical Trial Update: Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients [Phase 4]
A Phase 4 trial evaluating a fixed-dose intervention to enhance survival in patients with serious mental illness, including schizophrenia an…
-
CLINICAL_TRIALS trial_result · 2022-11-04Clinical Trial Update: Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol [Phase 1, Phase 2]
Phase 1/2 safety and pharmacokinetic study of RVX000222 in healthy subjects and individuals with low HDL cholesterol completed.
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: Phosphate Lowering in CKD Trial [Phase 4]
A Phase 4 trial examining phosphate lowering in chronic kidney disease with cardiovascular disease has completed and results were posted in …
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: SGLT-2 Inhibitor and Myocardial Perfusion, Function and Metabolism in T2 DM Patients at High Cardiovascular Risk [Phase 3]
Phase 3 trial update on an SGLT-2 inhibitor assessing effects on myocardial perfusion, function, and metabolism in type 2 diabetes patients …
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Trial of Oral Glutamine on Mitochondrial Function in CKD [Phase 2]
Phase 2 trial assessing oral glutamine effects on mitochondrial function in CKD; study completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-23Clinical Trial Update: Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention [Phase 2]
Phase 2 clinical trial update evaluating rivaroxaban for efficacy and safety in supporting elective percutaneous coronary intervention.
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: The Effect of Morphine on Prasugrel Absorption in STEMI Patients [Phase 4]
Phase 4 clinical trial investigating how morphine affects prasugrel absorption in STEMI patients has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-28Clinical Trial Update: Effects of Cardiac Rehabilitation (CR) on Functional Capacity and Cardiovascular Risk Factors [NA]
Clinical trial on cardiac rehabilitation assessing its effects on functional capacity and cardiovascular risk factors; study completed with …
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Impact of Plant Sterol Supplement on LDL-C Lowering in Low-to-Moderate Risk South Asian Patients [Phase 4]
Phase 4 trial evaluating the impact of plant sterol supplementation on LDL-C lowering in low-to-moderate risk South Asian patients; results …
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: A Randomized Controlled Trial of Stress Reduction on Cardiovascular Morbidity and Mortality in African Americans [Phase 2]
Phase 2 randomized trial evaluating stress reduction and its effects on cardiovascular morbidity and mortality in African Americans with cor…
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Metformin in Kidney Disease [Phase 2]
Phase 2 trial assessing metformin in chronic kidney disease with cardiovascular/metabolic syndrome comorbidity; completed with results poste…